Chris Abbosh MB

Chris is a Clinical Fellow under the supervision of Professor Charles Swanton at University College London. He works with patients enrolled in the lung TRACERx (TRAcking lung Cancer Evolution through treatment Rx) study. TRACERx is a multi-center study tasked with determining the impact of intratumor heterogeneity on clinical outcomes in lung cancer. Chris is focusing on cell-free DNA analyses arising from this study and is particularly interested in the application of this technology to stratify risk in adjuvant clinical trials.